BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35365182)

  • 1. A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis.
    Wang YW; Chen SC; Gu DL; Yeh YC; Tsai JJ; Yang KT; Jou YS; Chou TY; Tang TK
    J Biomed Sci; 2022 Apr; 29(1):24. PubMed ID: 35365182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
    Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
    Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of FoxM1 by HIF‑1α mediates hypoxia‑induced EMT in prostate cancer.
    Tang C; Liu T; Wang K; Wang X; Xu S; He D; Zeng J
    Oncol Rep; 2019 Oct; 42(4):1307-1318. PubMed ID: 31364741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
    Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
    J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
    Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
    J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
    Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
    BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation.
    Zhang H; Zhou Q; Shen W
    J Orthop Surg Res; 2022 Jul; 17(1):344. PubMed ID: 35799265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
    Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
    J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer.
    Zhang J; Niu Y; Huang C
    Recent Pat Anticancer Drug Discov; 2017; 12(3):247-259. PubMed ID: 28440206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
    Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
    J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis.
    Huang C; Qiu Z; Wang L; Peng Z; Jia Z; Logsdon CD; Le X; Wei D; Huang S; Xie K
    Cancer Res; 2012 Feb; 72(3):655-65. PubMed ID: 22194465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1.
    Yu CP; Yu S; Shi L; Wang S; Li ZX; Wang YH; Sun CJ; Liang J
    Mol Med Rep; 2017 Oct; 16(4):5181-5188. PubMed ID: 28849004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 17. β-Sitosterol suppresses hepatocellular carcinoma growth and metastasis via FOXM1-regulated Wnt/β-catenin pathway.
    Chen Y; Yang Y; Wang N; Liu R; Wu Q; Pei H; Li W
    J Cell Mol Med; 2024 Feb; 28(3):e18072. PubMed ID: 38063438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma.
    Fei W; Yan Y; Liu G; Peng B; Liu Y; Chen Q
    PeerJ; 2023; 11():e16306. PubMed ID: 37904848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.
    Wang J; Zhang Y; Dou Z; Jiang H; Wang Y; Gao X; Xin X
    J Cell Mol Med; 2019 Aug; 23(8):5566-5575. PubMed ID: 31187582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.